复星和p53:它们如何参与CRC可塑性和亡?
Aranka Brockmueller1, Constanze Buhrmann2, Amir Reza Moravejolahkami3
1Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, Ludwig-Maximilians-University Munich, Pettenkoferstr. 11, D-80336 Munich, Germany.
Journal of advanced research
|January 8, 2024
概括
复星是一种天然化合物,通过抑制癌细胞的可塑性和促进亡来对抗结肠直肠癌 (CRC). 它调节p53通路,提供一种新的治疗策略来对抗CRC进展和药物耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 自然产品化学 自然产品化学
背景情况:
- 结肠直肠癌 (CRC) 的发展与表观遗传和生活方式因素有关,促进细胞可塑性.
- 恶性可塑性使CRC细胞能够适应压力,促进表型多样性,表皮-介质细胞过渡 (EMT),癌症干细胞 (CSC) 和代谢重编程.
- 这种适应性增强了CRC的瘤生成潜力,耐药性和转移.
研究的目的:
- 审查目前关于白醇在结肠直肠癌 (CRC) 预防和治疗中的作用的研究.
- 阐明复星的调节机制,特别是它对CRC中的p53通路的影响.
- 探索白醇,p53信号传递和抑制癌细胞可塑性之间的联系.
主要方法:
- 关于白醇,p53信号和结直肠癌的已发表研究的文献评论.
- 对研究Resveratrol抗塑性作用的研究进行分析.
- 检查将p53调节与复星的抗癌性质联系在一起的机制.
主要成果:
- 复星通过诱导亡和抑制癌细胞可塑性,表现出强大的抗瘤特性.
- 复星调节p53信号通路,这是致癌的关键抑制剂.
- 聚醇对细胞异质性和表型变化的作用与p53调制有关.
结论:
- 通过p53通路调解的白醇的抗塑性作用,代表了预防和治疗CRC的有希望的策略.
- 了解这些机制可以为CRC改善治疗选择,准细胞迁移和耐药性.
- 复星对瘤蛋白p53信号的调节对于预防CRC的恶性表型变化至关重要.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:37DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K